Q2 2021 Holdings
Filed 2021-08-16 | 59 holdings | $575.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $230.8M | 4,220,048 | 40.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $200.8M | 1,526,359 | 34.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $33.0M | 1,752,346 | 5.7% |
| Celldex Therapeutics Inc(CLDX) | Common | 15117B202 | $32.4M | 968,906 | 5.6% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $24.1M | 1,374,279 | 4.2% |
| Cytokinetics Inc(CYTK) | Common | 23282W605 | $13.9M | 700,000 | 2.4% |
| Arcutis Biotherapeutics Inc(ARQT) | Common | 03969K108 | $11.8M | 433,585 | 2.1% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $11.4M | 137,411 | 2.0% |
| Codexis, Inc(CDXS) | Common | 192005106 | $8.8M | 388,144 | 1.5% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $6.5M | 500,732 | 1.1% |
| Instil Bio Inc | Common | 45783C101 | $241.2K | 12,486,787 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $190.5K | 11,639,929 | 0.0% |
| New Frontier Health Corp | Ord Shs | G6461G106 | $159.7K | 14,300,000 | 0.0% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $128.0K | 4,534,341 | 0.0% |
| Genetron Holdings Ltd | ADS | 37186H100 | $127.7K | 6,339,860 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $86.6K | 2,987,331 | 0.0% |
| Aligos Therapeutics Inc | Common | 01626L105 | $72.3K | 3,547,030 | 0.0% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $59.9K | 3,871,291 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $44.6K | 1,863,296 | 0.0% |
| Essa Pharma Inc(EPIEUR) | Common | 29668H708 | $44.3K | 1,551,680 | 0.0% |
| Legend Biotech Corp Sponsored(LEGN) | SPONSORED ADS | 52490G102 | $39.3K | 956,702 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | Common | 46583P102 | $37.6K | 5,966,527 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U404 | $37.3K | 1,917,074 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $34.7K | 1,238,575 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $32.8K | 2,675,133 | 0.0% |
| Zai Lab Ltd ADR(ZLAB) | ADR | 98887Q104 | $31.0K | 175,000 | 0.0% |
| Impel NeuroPharma Inc | Common | 45258K109 | $25.5K | 2,884,789 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $22.5K | 5,817,459 | 0.0% |
| Verona Pharma PLC ADR(VRNA) | ADS | 925050106 | $19.9K | 3,048,507 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $19.8K | 2,937,093 | 0.0% |
| Novavax Inc(NVAX) | Common | 670002401 | $18.7K | 88,046 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $17.3K | 1,328,257 | 0.0% |
| Nkarta Inc(NKTX) | Common | 65487U108 | $16.2K | 512,225 | 0.0% |
| Eiger BioPharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $15.3K | 1,791,257 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $13.4K | 4,220,938 | 0.0% |
| Curis Inc(CRISEUR) | Common | 231269200 | $12.5K | 1,553,500 | 0.0% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $12.3K | 872,151 | 0.0% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $12.2K | 577,642 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $11.0K | 525,262 | 0.0% |
| Design Therapeutics(DSGN) | Common | 25056L103 | $10.6K | 530,991 | 0.0% |
| Valneva SE(VALN) | SPONSORED ADS | 92025Y103 | $10.5K | 400,000 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $9.9K | 286,064 | 0.0% |
| Aslan Pharmaceuticals Ltd | ADS | 04522R101 | $9.4K | 2,840,909 | 0.0% |
| Merus NV | Common | N5749R100 | $9.3K | 442,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | Common | 80405P107 | $8.7K | 1,232,394 | 0.0% |
| Passage Bio Inc | Common | 702712100 | $8.6K | 646,001 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | Common | 517125100 | $7.9K | 799,662 | 0.0% |
| Elevation Oncology Inc | Common | 28623U101 | $6.7K | 496,843 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $6.2K | 853,143 | 0.0% |